| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
38,147 |
29,796 |
$5.62M |
| T2023 |
Targeted case management; per month |
12,326 |
11,129 |
$4.66M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
111,534 |
58,257 |
$3.87M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
76,381 |
43,055 |
$3.06M |
| H0038 |
Self-help/peer services, per 15 minutes |
113,461 |
35,353 |
$1.45M |
| H2027 |
Psychoeducational service, per 15 minutes |
20,568 |
17,393 |
$976K |
| 90832 |
Psychotherapy, 30 minutes with patient |
29,688 |
21,584 |
$866K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
30,949 |
16,947 |
$261K |
| 80305 |
|
44,862 |
17,262 |
$241K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,328 |
2,889 |
$217K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,089 |
3,593 |
$210K |
| 90791 |
Psychiatric diagnostic evaluation |
1,642 |
1,359 |
$95K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,833 |
1,241 |
$92K |
| 90837 |
Psychotherapy, 53 minutes with patient |
3,096 |
1,842 |
$84K |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
1,099 |
991 |
$68K |
| 99406 |
|
12,167 |
8,448 |
$66K |
| 81025 |
|
11,047 |
9,144 |
$56K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
531 |
487 |
$49K |
| 99442 |
|
1,191 |
475 |
$31K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,157 |
985 |
$24K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,157 |
985 |
$24K |
| 87563 |
|
1,181 |
986 |
$24K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,181 |
986 |
$24K |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
222 |
181 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
129 |
117 |
$6K |
| 99205 |
Prolong outpt/office vis |
170 |
82 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
274 |
229 |
$4K |
| 80053 |
Comprehensive metabolic panel |
580 |
498 |
$4K |
| 99441 |
|
192 |
96 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
516 |
437 |
$2K |
| 86803 |
|
274 |
228 |
$2K |
| 86705 |
|
274 |
228 |
$2K |
| 87340 |
|
269 |
228 |
$2K |
| 99443 |
|
27 |
15 |
$1K |
| H0027 |
Alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law) |
22 |
22 |
$0.00 |